MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
238 hedge funds and large institutions have $9.58B invested in Mirati Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 90 increasing their positions, 81 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
-7
Holders Change %
-2.86%
% of All Funds
4.18%
Holding in Top 10
15
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+25%
% of All Funds
0.26%
New
41
Increased
90
Reduced
81
Closed
46
Calls
$261M
Puts
$90M
Net Calls
+$171M
Net Calls Change
+$114M
Top Buyers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$280M |
| 2 |
Invesco
Atlanta,
Georgia
|
$122M |
| 3 |
AG
Artal Group
Luxembourg
|
$212M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
$609M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
$188M |
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
$42.2M |
| 2 |
Millennium Management
New York
|
$9.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
$6.7M |
| 4 |
BlackRock
New York
|
$470M |
| 5 |
HF
HRT Financial
New York
|
$0 |
